Related Experiment Videos
Disopyramide induced atypical ventricular tachycardia
Australian and New Zealand Journal of Medicine
|December 1, 1980
Summary
Oral disopyramide can cause atypical ventricular tachycardia, even at normal doses. Close monitoring for ventricular tachyarrhythmias is crucial, especially with a prolonged QTc interval.
Area of Science:
- Cardiology
- Clinical Pharmacology
Background:
- Disopyramide is an antiarrhythmic medication used to treat certain heart rhythm disorders.
- Adverse drug reactions, including cardiac arrhythmias, are a significant concern in pharmacotherapy.
Observation:
- A case study details a patient who developed atypical ventricular tachycardia.
- This occurred despite receiving standard oral doses of disopyramide over four months.
- The arrhythmia was preceded by significant QTc interval prolongation.
Findings:
- Oral disopyramide, at therapeutic doses, can induce serious ventricular tachyarrhythmias.
- QTc interval prolongation is a potential indicator of disopyramide-induced cardiotoxicity.
Implications:
- Healthcare providers should carefully monitor patients on oral disopyramide for ventricular tachyarrhythmias.
- Particular vigilance is required for patients exhibiting a prolonged QTc interval.
- This case highlights the importance of pharmacovigilance for antiarrhythmic drugs.